MV140 Vaccine Helped People Remain UTI-Free For Years

New Delhi: Urinary Tract Infection (UTI) is a common bacterial infection said to be experienced by half of all women and one in five men. However, a study has shown that more than 50 per cent of people remained UTI-free for up to nine years who received the oral spray-based vaccine ‘MV140’.

According to the study published in the journal European Association of Urology, the MV140 vaccine is a potential alternative to antibiotic treatments. About 54 per cent of study participants remained UTI-free for nine years after the vaccine, with no notable side effects reported.

“Recurrent infections, needing short-term antibiotic treatment, develop in between 20 to 30 per cent of cases,” the study mentioned. This study, conducted by specialists at the UK’s Royal Berkshire Hospital, examined the safety and efficacy of the MV140 vaccine in 89 patients.

“Nine years after first receiving this new UTI vaccine, around half of participants remained infection-free. Overall, this vaccine is safe in the long term and our participants reported having fewer UTIs that were less severe,” said Dr Bob Yang, Consultant Urologist at the Royal Berkshire NHS Foundation Trust, who co-led the study.

MV140 vaccine was administered with two sprays of a pineapple-flavoured suspension under the tongue every day for three months in patients.

Developed by the Spain-based pharmaceutical company Immunotek, MV140 contains four bacterial species in a suspension with water. It is available off-license in 26 countries. In the research, 48 participants remained entirely infection-free during the nine-year follow-up.

The average infection-free period across the cohort was 54.7 months (four and a half years) – 56.7 months for women and 44.3 months, one year less, for men. 40 per cent of participants reported having repeat doses of the vaccine after one or two years, the study noted.

“This follow-up study reveals encouraging data about the long-term safety and effectiveness of the MV140 vaccine,” said Gernot Bonkat, Professor at the Alta Uro Medical Centre for Urology in Switzerland.

Related Posts

Heart disease is no longer an age-defined illness: Experts

Heart disease is no longer a condition that can be viewed primarily through the lens of age. “We are increasingly seeing the importance of identifying cardiovascular risk much earlier, particularly…

Kingpin of counterfeit pharma racket arrested at Bengaluru airport after Sharjah return

The alleged kingpin of a multi-state counterfeit medicine racket was arrested after investigators seized drugs and equipment worth ₹5.05 crore. The 36-year-old alleged kingpin of a counterfeit pharmaceutical racket spanning…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Heart disease is no longer an age-defined illness: Experts

Heart disease is no longer an age-defined illness: Experts

Kingpin of counterfeit pharma racket arrested at Bengaluru airport after Sharjah return

Kingpin of counterfeit pharma racket arrested at Bengaluru airport after Sharjah return

Child rights panel seeks report on measles deaths in Keralam’s Malappuram

Child rights panel seeks report on measles deaths in Keralam’s Malappuram

Cancer, kidney, AIDS drugs sold at up to 70 times procurement cost: Karnataka Health Minister

Cancer, kidney, AIDS drugs sold at up to 70 times procurement cost: Karnataka Health Minister

CDSCO steps up scrutiny of pharma drugs containing narcotic substances

CDSCO steps up scrutiny of pharma drugs containing narcotic substances

Inquiry reveals ‘fake credentials, illegal diagnostic centres’ in Pilibhit; report sent to DM

Inquiry reveals ‘fake credentials, illegal diagnostic centres’ in Pilibhit; report sent to DM